The Can B Corp.’s (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A Growth Industry Seen Reaching $30 Billion At Retail By 2023
By
In NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: CWBHF, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

The Can B Corp.’s (OTCQB: CANB) Strategy Of Seed-To-Sale CBD Drives Company’s Vertically Integrated Success In Dynamic Market Compared To Competitors; Its Hemp-Sourced CBD Products Are Proprietary And Differentiated From Others In A Growth Industry Seen Reaching $30 Billion At Retail By 2023

In a competitive fast-growing CBD industry, The Can B Corp. (OTCQB: CANB) sets itself apart with a seed-to-sale marketing strategy that makes it vertically integrated and gives it hemp-sourced [...]

READ MORE
Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast
By
In CSE: CWBHF, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, TSX: ACB
Posted

Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Discusses Company’s Competitive Advantage, Product Diversification And Medical Impact Of Its CBD Products On The Stock Market Podcast

Can B Corp.’s (OTCQB: CANB) released today (October 29, 2020) an interview with Director and CFO, Stanley Teeple, on The Stock Market Podcast for an interview. He discussed with host Jane [...]

READ MORE
The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023
By
In CSE: CWEB, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NASDAQ:CRON, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023

The Can B Corp. (OTCQB: CANB) advantage: lab tested certification of hemp-sourced products, from Hemp Oils To CBD Gels, is a proven success. Documenting hemp-sourced CBD product quality is a [...]

READ MORE
Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Will Discuss New Product Launches, Its FDA-approved Medical Device And Successful Performance During Pandemic, On A Stock Market Podcast Interview
By
In CSE: CWBHF, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NASDAQ:CRON, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Can B Corp.’s (OTCQB: CANB) Stanley Teeple, Director And CFO, Will Discuss New Product Launches, Its FDA-approved Medical Device And Successful Performance During Pandemic, On A Stock Market Podcast Interview

Can B Corp. (OTCQB: CANB) today (October 23, 2020) announces that its Director and CFO, Stanley Teeple, has been invited by Stock Market Podcast for an interview. It is anticipated that he will [...]

READ MORE
Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November
By
In CSE: CWBHF, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NASDAQ:CRON, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Can B Corp. (OTCQB: CANB) Launches In Conjunction With Dr. Karl Zarse ImmuneX2, A Physician-Developed Proprietary Super Immune Boosting AM/PM Supplement Designed To Optimize The Health System Of Users Before Needed; Shipments Start In November

Can B Corp. (OTCQB: CANB), a diversified health and wellness developing company, announced yesterday it will begin shipping in November ImmuneX2 a physician-developed proprietary super immune [...]

READ MORE
Can B Corp. (OTCQB: CANB) Reports Progress On Phase Two Of Its Manufacturing Upgrade At Its Can B Superfood Facility As It Anticipates Growth And Vertical Integra-tion As ‘Seed To Sale’ Company
By
In CSE: CWBHF, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Can B Corp. (OTCQB: CANB) Reports Progress On Phase Two Of Its Manufacturing Upgrade At Its Can B Superfood Facility As It Anticipates Growth And Vertical Integra-tion As ‘Seed To Sale’ Company

Can B Corp. (OTCQB: CANB) has announced it is well underway in Phase Two of its upgrade manufacturing project at its Can B Superfood facility. In completed Phase One, state-of-the-art, high speed [...]

READ MORE
Can B Corp. (OTCQB: CANB) Plans A 2021 Modified Launch Of Its Licensed Life-Guard® Line of CBD And Non-CBD Products Including Such Products As Topicals And Beverages Plus A Skin Preserver Line Of Sunscreens, Lip Balms And Replenish Supplements
By
In CSE: CWBHF, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Can B Corp. (OTCQB: CANB) Plans A 2021 Modified Launch Of Its Licensed Life-Guard® Line of CBD And Non-CBD Products Including Such Products As Topicals And Beverages Plus A Skin Preserver Line Of Sunscreens, Lip Balms And Replenish Supplements

Can B Corp. (OTCQB: CANB) plans a 2021 launch of its licensed LifeGuard® line of CBD and non-CBD products, including its Skin Preserver line of sunscreens, lip balms and replenish supplements. [...]

READ MORE
Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi’s, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar
By
In CSE: CWEB, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Strong Gross Margins Of Almost 77% Help Drive Can B Corp.’s (OTCQB: CANB) Marco Alfonsi’s, CEO, Optimism About The Company’s Financial Performance As Hemp-Derived CBD Products Soar

One of the reasons that Marco Alfonsi, CEO, is so optimistic about the future financial performance of Can B Corp. (OTCQB: CANB) are the strong gross margins of almost 77% the CBD company has [...]

READ MORE
Cannabis Financial 2020 Reports From Leaders Shows Strong Future: Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), GW Pharmaceuticals (NASDAQ: GWPH), cbdMD (NYSE: YCBD) And Can B Corp. (OTCQB: CANB)
By
In CSE: CWBHF, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NASDAQ:CRON, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTCQB: CANB, TSX: ACB
Posted

Cannabis Financial 2020 Reports From Leaders Shows Strong Future: Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), GW Pharmaceuticals (NASDAQ: GWPH), cbdMD (NYSE: YCBD) And Can B Corp. (OTCQB: CANB)

Despite the impact of COVID-19, the CBD cannabis industry is reporting financial performance that supports its anticipation of a solid long term future as a growth industry. Even through the [...]

READ MORE
Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More
By
In CSE: CWEB, NASDAQ: CRON, NASDAQ: GWPH, NASDAQ: INSY, NASDAQ: JOYG, NYSE: ACB, NYSE: CGC, NYSE: YCBD, OTC: SPRWF, OTCQB: CANB, TSX: ACB
Posted

Cannabis Seen Reaching $30 billion At Retail By 2023; Can B Corp. (OTCQB: CANB) Plays Key Role In Industry Growth With Its Hemp-Derived Diverse Marketing Of CBD Lines Of Tinctures, Oils, Creams And More

The cannabis CBD industry sees a bright future of reaching $30 billion at retail by 2023, as reported by Digital Privacy News and Bloomberg from research by Marijuana Business Daily. Medical [...]

READ MORE
1 2 3 4
page 1 of 4